4 active trials 4 recruiting 1 Phase 3 2 disease areas
| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06765109 | Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC | Non-small Cell Lung Cancer | Recruiting | 2026-09-30 |
| Phase 1/2 | ||||
| NCT05118789 | A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors… | Locally Advanced Solid Tumor | Recruiting | 2026-09-24 |
| NCT05384626 | A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors… | Locally Advanced Solid Tumor | Recruiting | 2026-05-27 |
| Phase 1 | ||||
| NCT06521554 | A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) | Locally Advanced Solid Tumor | Recruiting | 2026-02-25 |